nds in RBO could modulate the activities of β-site amyloid precursor protein cleaving enzyme 1 (BACE1), mitogen-activated protein kinase 3 (MAPK3), matrix metalloproteinase 3 (MMP3), and intercellular adhesion molecule 1 (ICAM1), leading to inhibition of Aβ accumulation and Tau protein hyper-phosphorylation. Moreover, RBO reduced Aβ-induced oxidative stress by inhibiting the activity of mouse double minute 2 homolog (MDM2) and cyclic adenosine monophosphate response element binding protein binding protein (CREBBP), and attenuated neuroinflammation by inhibiting the activity of nitric oxide synthase 2 (NOS2) and reducing Aβ accumulation and Tau protein hyperphosphorylation. Additionally, α-linolenic acid in RBO exhibited inhibitory effects on D-gal-induced apoptosis in PC12 cells through modulation of NOS2, MDM2, ICAM1, and phospho-extracellular signal-regulated kinase 1/2 (p-ERK1/2). Similarly, stigmastanol inhibited apoptosis in D-gal-induced PC12 cells through the regulation of NOS2. Thus, RBO can be considered as a potential functional food to attenuate AD owing to its multicomponent and multitarget effects.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: